- Home
- PTGX vs FIHL Comparison
PTGX vs FIHL Comparison
Compare PTGX & FIHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- FIHL
- Stock Information
- Founded
- PTGX 2006
- FIHL 2014
- Country
- PTGX United States
- FIHL Bermuda
- Employees
- PTGX N/A
- FIHL N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- FIHL
- Sector
- PTGX Health Care
- FIHL
- Exchange
- PTGX Nasdaq
- FIHL Nasdaq
- Market Cap
- PTGX 3.3B
- FIHL 1.8B
- IPO Year
- PTGX 2016
- FIHL 2023
- Fundamental
- Price
- PTGX $53.00
- FIHL $15.72
- Analyst Decision
- PTGX Strong Buy
- FIHL Hold
- Analyst Count
- PTGX 9
- FIHL 7
- Target Price
- PTGX $67.11
- FIHL $20.43
- AVG Volume (30 Days)
- PTGX 923.4K
- FIHL 792.7K
- Earning Date
- PTGX 08-05-2025
- FIHL 08-13-2025
- Dividend Yield
- PTGX N/A
- FIHL 2.51%
- EPS Growth
- PTGX N/A
- FIHL N/A
- EPS
- PTGX 0.86
- FIHL N/A
- Revenue
- PTGX $207,801,000.00
- FIHL $2,558,400,000.00
- Revenue This Year
- PTGX N/A
- FIHL $18.84
- Revenue Next Year
- PTGX $53.09
- FIHL $8.21
- P/E Ratio
- PTGX $61.48
- FIHL N/A
- Revenue Growth
- PTGX N/A
- FIHL 23.93
- 52 Week Low
- PTGX $32.50
- FIHL $14.17
- 52 Week High
- PTGX $60.60
- FIHL $21.32
- Technical
- Relative Strength Index (RSI)
- PTGX 53.99
- FIHL 39.42
- Support Level
- PTGX $49.38
- FIHL $15.75
- Resistance Level
- PTGX $51.51
- FIHL $16.98
- Average True Range (ATR)
- PTGX 2.02
- FIHL 0.40
- MACD
- PTGX -0.39
- FIHL -0.03
- Stochastic Oscillator
- PTGX 46.09
- FIHL 8.70
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About FIHL Fidelis Insurance Holdings Limited
Fidelis Insurance Holdings Ltd is a specialty insurer that leverages strategic partnerships to offer tailored insurance solutions. The company classifies its business into two segments, Insurance and Reinsurance. A majority of its revenue is generated from the Insurance segment, which comprises a portfolio of property, marine, aviation and aerospace, political risk, violence and terror, energy, cyber, and other insurance risks. The Reinsurance segment consists of an actively managed property reinsurance book, providing reinsurance and a limited amount of retrocession coverage across the world on a proportional or excess-of-loss basis. Geographically, the company derives its key revenue from the United Kingdom, followed by Bermuda and the Republic of Ireland.